LAURA INGRAHAM (HOST): Dr. McCullough, this was a bad week for those who made it their business to bash early-use therapeutics. It's not just hydroxychloroquine; they've done it with ivermectin, even simple things like a vitamin D deficiency. Your thoughts?
DR. PETER MCCULLOUGH: Well, my thoughts are that Sen. Johnson was right by holding these early-treatment hearings in November and December, and Americans saw the effort of early treatment which crushed the epidemic curve towards the end of December into January.
Since that time, we've been on a low, controllable plateau of COVID-19 cases. Doctors who were really following the data were using hydroxychloroquine. It works best early in combination with other drugs, and as Dr. Smith points out, following along with the Henry Ford hospital, which is the largest hydroxychloroquine study, still weighing to date on hospitalized patients, early use of hydroxychloroquine in the hospital clearly worked, reduced mortality, and should be used as a standard of care.